Br J Haematol 2020 Mar 5
Early experience using salvage radiotherapy for relapsed/refractory non-Hodgkin lymphomas after CD19 chimeric antigen receptor (CAR) T cell therapy.
Related Questions
New comment by Radiation Oncologist at Mayo Clinic College of Medicine and Science (Jacksonville) ( August 8, 2024)
We published our Mayo Clinic algorithm on this (Saifi et al., PMID 37950857). It has all the information needed on radiation timing, dose, and volumes.